Sharon Levy, MD, MPH, Boston Children’s Hospitals, Chief, Division of Addiction Medicine, was promoted to Professor of Pediatrics at Harvard Medical School. Roger Weiss, MD, Professor of Psychiatry at Harvard Medical School, and Chief of the Division of Alcohol, Drugs, and Addiction at McLean Hospital received the Founders Award from the American Academy of Addiction Psychiatry. Gail D’Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Medicine and Public Health, Yale University was elected to the National Academy of Medicine. CTN-0131 The NECN, the Lead Node of CTN-0131, hosted the Methadone Clinician Education and Support Training,held on 10/2, in Fitkin Auditorium on the campus of Yale School of Medicine. Physicians,…

Gwen Lapham, PhD, MPH, MSW, recently published Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal, in JAMA Network Open. Dr. Lapham led the CTN-0077 study and is a PROUD (CTN-0074) co-investigator and Kaiser Permanente Washington Health Research Institute (KPWHRI) assistant investigator and addictions health services researcher.  She is also an assistant affiliate professor in the Department of Health Systems and Population Health, University of Washington, and assistant professor in the Kaiser Permanente Bernard J. Tyson School of Medicine. Since joining KPWHRI, she has capitalized on her prior social work and health services training to do impactful research on evidence-based primary care…

(pictured above: John Rotrosen, Ned Nunes, and Jennifer McNeely, leadership of the NY Node) The NYU Grossman School of Medicine’s Department of Psychiatry had retirement party on October 4th celebrating John Rotrosen MD and his remarkable career! John joined NYU in 1968 as a medical student, stayed on through a research residency in psychiatry, and since, as faculty, most of that time overseeing clinical and research programs at Bellevue Hospital and the VA, with generous research funding mostly from the NIH and the VA.  A highlight of all of those years has been his team’s association with NIDA’s CTN since its inception in 2000, and especially since 2010 with the merger…

The Learning for Early Careers in Addiction and Diversity (LEAD) program, a NIDA-funded science education program focused on addictions research training is recruiting a new cohort of scholars. The program trains early career substance use disorder researchers from racial/ethnic minoritized groups that are underrepresented as NIH funded investigators. The program announcement includes eligibility criteria and instructions about how to submit an application for consideration. Find the application here. The requirements are on the application, which include the following: Posted October 13, 2023

Andrew Saxon, MD (VA Puget Sound, UW Dept of Psychiatry & Behavioral Sciences), and Joseph Merrill, MD (UW Medicine), both long-time members of the CTN’s Pacific Northwest Node, were recently included in Seattle Met Magazine’s “Top Docs of 2023” feature (both in the category of Addiction Medicine). Congratulations, Drs. Saxon and Merrill, and thank you for your continued support of the CTN and the Pacific Northwest Node! Posted October 12, 2023

New England Consortium Node member: Angela Haeny, PhD, assistant professor of psychiatry and director of the Racial Equity & Addiction Lab, was the recipient of the 2023 Early Career Investigator Award from the Translational Mechanisms of Behavior Change (MOBC) Satellite Meeting at the Research Society on Alcohol (RSA). New Publication including NEC Node members: Ren Boyu, Lipsitz Stuart R, Weiss Roger D, Fitzmaurice Garrett M. Methods for handling missing binary data in substance use disorder trials. Drug Alcohol Depend. 2023 Sep 1;250:110897. doi: 10.1016/j.drugalcdep.2023.110897. Epub 2023 Jul 13. PMID: 37544038 New Publication including NEC Node members: Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker…

NIDA News Release Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl. NIDA News, March 30, 2023. Referencing findings: D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 New Publication Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. J Subst Use Addict Treat. 2023 Apr 4;149:209030. doi: 10.1016/j.josat.2023.209030. Epub ahead of print. PMID: 37023858. Posted April…